headline: COVID-19 special envoy David Nabarro dies at 75
ByAinvest
Saturday, Jul 26, 2025 8:44 am ET1min read
OVID--
Nabarro, a British public health expert, was known for his significant contributions to global health and his advocacy for health equity. He was also co-director of the Institute of Global Health Innovation at Imperial College in London. Throughout his career, Nabarro was a prominent figure in global health, having served as a candidate for WHO director general in 2017, where he finished second to Tedros Adhanom Ghebreyesus [1].
At the height of the pandemic in 2021, Nabarro called for increased global cooperation and aid to poorer countries, emphasizing the severity of the health crisis, which he described as "nothing like anything else we've ever seen in my professional life" [1]. His commitment to global health and his leadership during the pandemic have left a lasting impact on the international health community.
The WHO chief, Tedros Adhanom Ghebreyesus, paid tribute to Nabarro, stating, "David was a great champion of global health and health equity, and a wise, generous mentor to countless individuals" [1]. His legacy will continue to influence global health policies and initiatives aimed at improving health outcomes worldwide.
References:
[1] https://www.reuters.com/business/healthcare-pharmaceuticals/covid-19-special-envoy-david-nabarro-dies-75-2025-07-26/
[2] https://www.marketscreener.com/news/19-special-envoy-david-nabarro-dies-at-75-ce7c5fdbd18ef32d
headline: COVID-19 special envoy David Nabarro dies at 75
David Nabarro, the World Health Organization's (WHO) special envoy for COVID-19 since the early stages of the outbreak in 2020, has passed away at the age of 75, as announced by the WHO on Saturday, July 26, 2025 [1].Nabarro, a British public health expert, was known for his significant contributions to global health and his advocacy for health equity. He was also co-director of the Institute of Global Health Innovation at Imperial College in London. Throughout his career, Nabarro was a prominent figure in global health, having served as a candidate for WHO director general in 2017, where he finished second to Tedros Adhanom Ghebreyesus [1].
At the height of the pandemic in 2021, Nabarro called for increased global cooperation and aid to poorer countries, emphasizing the severity of the health crisis, which he described as "nothing like anything else we've ever seen in my professional life" [1]. His commitment to global health and his leadership during the pandemic have left a lasting impact on the international health community.
The WHO chief, Tedros Adhanom Ghebreyesus, paid tribute to Nabarro, stating, "David was a great champion of global health and health equity, and a wise, generous mentor to countless individuals" [1]. His legacy will continue to influence global health policies and initiatives aimed at improving health outcomes worldwide.
References:
[1] https://www.reuters.com/business/healthcare-pharmaceuticals/covid-19-special-envoy-david-nabarro-dies-75-2025-07-26/
[2] https://www.marketscreener.com/news/19-special-envoy-david-nabarro-dies-at-75-ce7c5fdbd18ef32d

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet